The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation

Panagiotis Tryphonopoulos, Andreas G. Tzakis, Debbie Weppler, Rolando Garcia-Morales, Tomoaki Kato, Juan R. Madariaga, David M. Levi, Seigo Nishida, Jang Moon, Gennaro Selvaggi, Arie Regev, Caio Nery, Pablo Bejarano, Amr Khaled, Gary Kleiner, Violet Esquenazi, Joshua Miller, Phillip Ruiz, Camillo Ricordi

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

We investigated the role of donor bone marrow cell (DBMC) infusions in immunosuppression withdrawal in adult liver transplantation. Patients enrolled were at least 3 years post-transplantation, with stable graft function. Forty-five (study group: G1) received DBMC, and 59 (control group: G2) did not. Immunosuppression was reduced by one third upon enrollment, by another third the second year of the study and was completely withdrawn the third year. Patient and graft survival were similar between the two groups. Although rejection episodes were significantly less in G1 the first 2 years of the study (35% vs. 57%, p = 0.016), there was no significant difference overall (74% vs. 81%, p = 0.14). Until February 2004, 20 patients, 10 in each group, were immunosuppression free for 1-3 years. Approximately 20% of long-term survivors of liver transplantation can successfully discontinue their immunosuppression. DBMC infusions, do not increase this likelihood.

Original languageEnglish
Pages (from-to)608-613
Number of pages6
JournalAmerican Journal of Transplantation
Volume5
Issue number3
DOIs
StatePublished - Mar 1 2005

Fingerprint

Immunosuppression
Bone Marrow
Tissue Donors
Bone Marrow Cells
Liver
Liver Transplantation
Graft Survival
Survivors
Transplantation
Transplants
Control Groups

Keywords

  • Donor bone narrow infusion
  • Immunosuppression withdrawal
  • Liver transplantation
  • Tolerance

ASJC Scopus subject areas

  • Immunology

Cite this

The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. / Tryphonopoulos, Panagiotis; Tzakis, Andreas G.; Weppler, Debbie; Garcia-Morales, Rolando; Kato, Tomoaki; Madariaga, Juan R.; Levi, David M.; Nishida, Seigo; Moon, Jang; Selvaggi, Gennaro; Regev, Arie; Nery, Caio; Bejarano, Pablo; Khaled, Amr; Kleiner, Gary; Esquenazi, Violet; Miller, Joshua; Ruiz, Phillip; Ricordi, Camillo.

In: American Journal of Transplantation, Vol. 5, No. 3, 01.03.2005, p. 608-613.

Research output: Contribution to journalArticle

Tryphonopoulos, P, Tzakis, AG, Weppler, D, Garcia-Morales, R, Kato, T, Madariaga, JR, Levi, DM, Nishida, S, Moon, J, Selvaggi, G, Regev, A, Nery, C, Bejarano, P, Khaled, A, Kleiner, G, Esquenazi, V, Miller, J, Ruiz, P & Ricordi, C 2005, 'The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation', American Journal of Transplantation, vol. 5, no. 3, pp. 608-613. https://doi.org/10.1111/j.1600-6143.2004.00743.x
Tryphonopoulos, Panagiotis ; Tzakis, Andreas G. ; Weppler, Debbie ; Garcia-Morales, Rolando ; Kato, Tomoaki ; Madariaga, Juan R. ; Levi, David M. ; Nishida, Seigo ; Moon, Jang ; Selvaggi, Gennaro ; Regev, Arie ; Nery, Caio ; Bejarano, Pablo ; Khaled, Amr ; Kleiner, Gary ; Esquenazi, Violet ; Miller, Joshua ; Ruiz, Phillip ; Ricordi, Camillo. / The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. In: American Journal of Transplantation. 2005 ; Vol. 5, No. 3. pp. 608-613.
@article{bce9890b6cf14a599cc75b9cf25db093,
title = "The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation",
abstract = "We investigated the role of donor bone marrow cell (DBMC) infusions in immunosuppression withdrawal in adult liver transplantation. Patients enrolled were at least 3 years post-transplantation, with stable graft function. Forty-five (study group: G1) received DBMC, and 59 (control group: G2) did not. Immunosuppression was reduced by one third upon enrollment, by another third the second year of the study and was completely withdrawn the third year. Patient and graft survival were similar between the two groups. Although rejection episodes were significantly less in G1 the first 2 years of the study (35{\%} vs. 57{\%}, p = 0.016), there was no significant difference overall (74{\%} vs. 81{\%}, p = 0.14). Until February 2004, 20 patients, 10 in each group, were immunosuppression free for 1-3 years. Approximately 20{\%} of long-term survivors of liver transplantation can successfully discontinue their immunosuppression. DBMC infusions, do not increase this likelihood.",
keywords = "Donor bone narrow infusion, Immunosuppression withdrawal, Liver transplantation, Tolerance",
author = "Panagiotis Tryphonopoulos and Tzakis, {Andreas G.} and Debbie Weppler and Rolando Garcia-Morales and Tomoaki Kato and Madariaga, {Juan R.} and Levi, {David M.} and Seigo Nishida and Jang Moon and Gennaro Selvaggi and Arie Regev and Caio Nery and Pablo Bejarano and Amr Khaled and Gary Kleiner and Violet Esquenazi and Joshua Miller and Phillip Ruiz and Camillo Ricordi",
year = "2005",
month = "3",
day = "1",
doi = "10.1111/j.1600-6143.2004.00743.x",
language = "English",
volume = "5",
pages = "608--613",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation

AU - Tryphonopoulos, Panagiotis

AU - Tzakis, Andreas G.

AU - Weppler, Debbie

AU - Garcia-Morales, Rolando

AU - Kato, Tomoaki

AU - Madariaga, Juan R.

AU - Levi, David M.

AU - Nishida, Seigo

AU - Moon, Jang

AU - Selvaggi, Gennaro

AU - Regev, Arie

AU - Nery, Caio

AU - Bejarano, Pablo

AU - Khaled, Amr

AU - Kleiner, Gary

AU - Esquenazi, Violet

AU - Miller, Joshua

AU - Ruiz, Phillip

AU - Ricordi, Camillo

PY - 2005/3/1

Y1 - 2005/3/1

N2 - We investigated the role of donor bone marrow cell (DBMC) infusions in immunosuppression withdrawal in adult liver transplantation. Patients enrolled were at least 3 years post-transplantation, with stable graft function. Forty-five (study group: G1) received DBMC, and 59 (control group: G2) did not. Immunosuppression was reduced by one third upon enrollment, by another third the second year of the study and was completely withdrawn the third year. Patient and graft survival were similar between the two groups. Although rejection episodes were significantly less in G1 the first 2 years of the study (35% vs. 57%, p = 0.016), there was no significant difference overall (74% vs. 81%, p = 0.14). Until February 2004, 20 patients, 10 in each group, were immunosuppression free for 1-3 years. Approximately 20% of long-term survivors of liver transplantation can successfully discontinue their immunosuppression. DBMC infusions, do not increase this likelihood.

AB - We investigated the role of donor bone marrow cell (DBMC) infusions in immunosuppression withdrawal in adult liver transplantation. Patients enrolled were at least 3 years post-transplantation, with stable graft function. Forty-five (study group: G1) received DBMC, and 59 (control group: G2) did not. Immunosuppression was reduced by one third upon enrollment, by another third the second year of the study and was completely withdrawn the third year. Patient and graft survival were similar between the two groups. Although rejection episodes were significantly less in G1 the first 2 years of the study (35% vs. 57%, p = 0.016), there was no significant difference overall (74% vs. 81%, p = 0.14). Until February 2004, 20 patients, 10 in each group, were immunosuppression free for 1-3 years. Approximately 20% of long-term survivors of liver transplantation can successfully discontinue their immunosuppression. DBMC infusions, do not increase this likelihood.

KW - Donor bone narrow infusion

KW - Immunosuppression withdrawal

KW - Liver transplantation

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=20044361820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044361820&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2004.00743.x

DO - 10.1111/j.1600-6143.2004.00743.x

M3 - Article

C2 - 15707417

AN - SCOPUS:20044361820

VL - 5

SP - 608

EP - 613

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 3

ER -